The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPathfinder Minerals Regulatory News (PFP)

  • This share is currently suspended. It was suspended at a price of 0.275

Share Price Information for Pathfinder Minerals (PFP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.275
PFP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Warrant Exercise, CLN Repayment and TVR

7 Oct 2020 11:57

RNS Number : 3978B
Pathfinder Minerals Plc
07 October 2020
 

7 October 2020

Pathfinder Minerals Plc

("Pathfinder" or the "Company")

 

Warrant Exercise, CLN Repayment and TVR

 

Pathfinder announces that it has received notice of the exercise of warrants to subscribe for a total of 1,166,666 new ordinary shares of 0.1p each in the capital of the Company ("Ordinary Shares"). These warrants were issued as part of the Company's Convertible Loan Note fundraising announced on 3 April 2020 ("April 2020 CLN") and the exercise price of these warrants was 0.6p per warrant.

As documented in the April 2020 CLN agreement, the funds received by the Company in relation to the exercise of these warrants will be netted off against the principal repayments due to the applicable April 2020 CLN holders on 1 December 2020. As such, the outstanding principal amount has further reduced from £109,000 to £102,000.

The interest due on the April 2020 CLN has also been reduced as a result of the exercise of warrants from £6,752 to £6,568 at expiry on 1 December 2020. No other terms of the April 2020 CLN have been affected.

Application for Admission to Trading on AIM and Total Voting Rights

Application will be made for the 1,166,666 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will occur on or around 14 October 2020.

Upon Admission, the Company's issued share capital will consist of 372,390,497 Ordinary Shares with one voting right each. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares and voting rights in the Company will be 372,390,497. With effect from Admission, this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

Dennis Edmonds, Chairman of Pathfinder, commented:

 

"The exercise of these warrants, at what is the current market price, coupled with the positions recently taken by the Chief Executive Officer, Non-Executive Director and a major shareholder, is testament to the confidence that exists within the Pathfinder Board of achieving a resolution to the licence dispute over Mining Concession 4623C in Mozambique. We look forward to updating the market in the near future."

 

 

Enquiries:

Pathfinder Minerals Plc

Peter Taylor, Chief Executive Officer

Tel. +44 +44 (0)20 3143 6748

 

Strand Hanson Limited (Nominated & Financial Adviser and Broker)

James Spinney / Ritchie Balmer / Jack Botros

Tel. +44 (0)20 7409 3494

 

Vigo Communications (Public Relations)

Ben Simons / Simon Woods

Tel. +44 (0)20 7390 0234

Email. pathfinderminerals@vigocomms.com

 

Novum Securities Limited (Broker)

Colin Rowbury / Jon Belliss

Tel. +44 (0)20 7399 9400

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR").

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRUPGAAUUPUGUM
Date   Source Headline
3rd Oct 20063:32 pmRNSSignificant Shareholding
29th Sep 20063:56 pmRNSInterim Results
11th Sep 20063:41 pmRNSSignificant Shareholding
11th Sep 20063:37 pmRNSResult of AGM
7th Jul 20064:12 pmRNSShareholdings
30th Jun 200612:12 pmRNSFinal Results
9th May 20064:25 pmRNSShareholding
21st Apr 20067:00 amRNSSale of Property
3rd Oct 20053:34 pmRNSDirectors' Dealings
30th Sep 20054:40 pmRNSInterim Results
22nd Sep 20055:03 pmRNSAGM Statement
12th Jan 20054:01 pmRNSEGM Statement
4th Jan 20054:30 pmRNSPremliminary Results Amendmnt

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.